Findings from UMSOP researchers and collaborators point to a promising new strategy for treating a broad range of cancers.

The nearly $1.3 million in funding from the University of Maryland Strategic Partnership supports early-career researchers across all seven UMB schools.

Students presented regulatory strategies that address emerging risks and enhance consumer safety in both traditional health care and rapidly expanding digital marketplaces.

The two-year study will help ensure patient and community perspectives are meaningfully included in research.

Dr. Julia Slejko’s research reveals that Americans value fairness in health outcomes, emphasizing the importance of equity in health care decision-making.

Dr. Nicole Brandt is working to deliver wellness services to older adults in senior housing to remove barriers such as transportation.

Researchers are advancing innovative science and health services research while improving patient care through groundbreaking funded projects.

Dr. Steven Fletcher’s new grant fuels collaborative training bridging chemistry and biology at UMSOP and UMBC.

Ryan Pearson’s team will explore how engineered nanoparticles can safely retrain the immune system to reduce allergic airway inflammation.

Computer modeling finds the most promising compounds and guides their transformation into drugs.

Study will explore how an antibiotic-resistant bacterium survives in the body and how that knowledge could lead to new, more effective treatments.

Researchers aim to improve chemotherapy by enhancing drug efficacy and reducing heart toxicity through dual activation of CAR and Nrf2 pathways.